title: Lipid abnormalities in black renal patients.
abstract: Racial differences in lipoprotein (LP) and cardiovascular (CV) abnormalities have been noted in the general population and in the population of patients on dialysis. Few studies have investigated the interaction of race and LP and CV disturbances in other renal disease groups. We studied lipid profiles and risk ratios (total cholesterol (TC)/high density lipoprotein-cholesterol) (HDL-C) and apolipoprotein (apo) A-I/apo B (A-I/B)) and the influence of race across a spectrum of renal disease groups (normal renal function (NRD), nephrotic range proteinuria (NS), hemodialysis (HD), continuous ambulatory peritoneal dialysis (CAPD), post-transplant (TR), renal insufficiency (RI)). We also performed a longitudinal study of lipid profiles in patients with end stage renal disease (ESRD) and the relationship of these profiles to race and other variables. There was a general tendency towards a better CV risk profile for blacks than whites in all the groups. Blacks tended to have lower TC, higher HDL-C, lower TC/HDL-C, higher apo A-I, lower apo B, and higher A-I/B. We analyzed four yearly cross-sections of the HD and CAPD populations using ANOVA with adjustment for appropriate covariates. Whites had lower HDL-C and a higher TC/HDL-C risk ratio than blacks. HD patients had lower TC, TC/HDL-C, apo A-I, and apo B than CAPD patients, and women had higher TC than men. When lipid profiles were studied longitudinally by yearly intervals, no consistent significant changes were seen, but over two years, levels of apo B fell and A-I/B rose. Race had no significant effect on any of the longitudinal data.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Long Island College Hospital, Avram Center for Kidney Disease, Brooklyn, NY 11201.
authors.forename: D E
authors.initials: DE
authors.lastname: Burrell
authors.forename: A
authors.initials: A
authors.lastname: Antignani
authors.forename: P
authors.initials: P
authors.lastname: Goldwasser
authors.forename: N
authors.initials: N
authors.lastname: Mittman
authors.forename: P A
authors.initials: PA
authors.lastname: Fein
authors.forename: P A
authors.initials: PA
authors.lastname: Slater
authors.forename: A
authors.initials: A
authors.lastname: Gan
authors.forename: M M
authors.initials: MM
authors.lastname: Avram
mesh_terms: D044383:Black People; D003327:Coronary Disease / Q000097:blood*; D003430:Cross-Sectional Studies; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D016030:Kidney Transplantation / Q000502:physiology; D008055:Lipids / Q000097:blood*; D008137:Longitudinal Studies; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D012307:Risk Factors
chemical_list: D008055:Lipids